HCG has identified the need for early and accurate diagnosis as vital in the treatment of cancer. Triesta, a wholly owned subsidiary of HCG, provides world-class diagnosis at its pathology labs. It also extends its diagnostic services to leading international hospitals and medical institutions.

Triesta’s integrated molecular pathology lab houses a biorepository dedicated to cancer. It also has a team of researchers who design, conduct and manage research projects that spearhead innovation in the field of cancer treatment.

To know more, log on to Triesta